Literature DB >> 19737512

IKKepsilon: a bridge between obesity and inflammation.

Jerrold M Olefsky1.   

Abstract

Obesity leads to tissue inflammation and insulin resistance, which are features of metabolic diseases such as type 2 diabetes. Chiang et al. (2009) now show that the IkappaB kinase IKKepsilon is an important link between obesity and inflammation and may be a new therapeutic target for treating obesity-related metabolic diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737512     DOI: 10.1016/j.cell.2009.08.018

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  16 in total

1.  Evidence for activation of inflammatory lipoxygenase pathways in visceral adipose tissue of obese Zucker rats.

Authors:  Swarup K Chakrabarti; Yeshao Wen; Anca D Dobrian; Banumathi K Cole; Qian Ma; Hong Pei; Michael D Williams; Melissa H Bevard; George E Vandenhoff; Susanna R Keller; Jiali Gu; Jerry L Nadler
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-10-26       Impact factor: 4.310

2.  Enriched environment inhibits breast cancer progression in obese models with intact leptin signaling.

Authors:  Grant D Foglesong; Nicholas J Queen; Wei Huang; Kyle J Widstrom; Lei Cao
Journal:  Endocr Relat Cancer       Date:  2019-05       Impact factor: 5.678

3.  Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes.

Authors:  Kitt Falk Petersen; Sylvie Dufour; Katsutaro Morino; Peter S Yoo; Gary W Cline; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

4.  Hypoxia-inducible factor 1α regulates a SOCS3-STAT3-adiponectin signal transduction pathway in adipocytes.

Authors:  Changtao Jiang; Jung-Hwan Kim; Fei Li; Aijuan Qu; Oksana Gavrilova; Yatrik M Shah; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

5.  Functional metagenomics: a high throughput screening method to decipher microbiota-driven NF-κB modulation in the human gut.

Authors:  Omar Lakhdari; Antonietta Cultrone; Julien Tap; Karine Gloux; Françoise Bernard; S Dusko Ehrlich; Fabrice Lefèvre; Joël Doré; Hervé M Blottière
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

6.  Anti-inflammatory nutrition as a pharmacological approach to treat obesity.

Authors:  Barry Sears; Camillo Ricordi
Journal:  J Obes       Date:  2010-09-30

7.  IKKε knockout prevents high fat diet induced arterial atherosclerosis and NF-κB signaling in mice.

Authors:  Changchun Cao; Yifan Zhu; Wen Chen; Liangpeng Li; Yongchao Qi; Xiaodi Wang; Ye Zhao; Xin Wan; Xin Chen
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Maternal undernutrition and cardiometabolic disease: a Latin American perspective.

Authors:  Patricio Lopez-Jaramillo; Diego Gomez-Arbelaez; Aristides Sotomayor-Rubio; Daniel Mantilla-Garcia; Jose Lopez-Lopez
Journal:  BMC Med       Date:  2015-03-02       Impact factor: 8.775

9.  The A2b adenosine receptor modulates glucose homeostasis and obesity.

Authors:  Hillary Johnston-Cox; Milka Koupenova; Dan Yang; Barbara Corkey; Noyan Gokce; Melissa G Farb; Nathan LeBrasseur; Katya Ravid
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

Review 10.  Obesity-Driven Gut Microbiota Inflammatory Pathways to Metabolic Syndrome.

Authors:  Luiz H A Cavalcante-Silva; José G F M Galvão; Juliane Santos de França da Silva; José M de Sales-Neto; Sandra Rodrigues-Mascarenhas
Journal:  Front Physiol       Date:  2015-11-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.